Loopbaan van Denis Drygin
Eerdere bekende functies van Denis Drygin
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| REGULUS THERAPEUTICS INC. | Hoofd Techniek/Wetenschap/O&O | 03-08-2020 | 29-11-2022 |
Pimera, Inc.
 Pimera, Inc. Financial ConglomeratesFinance Pimera, Inc. provides investment services. The company is headquartered in San Diego, CA. | Oprichter | 01-01-2013 | 31-07-2020 |
| Corporate Officer/Principal | 01-01-2013 | 31-07-2020 | |
Cylene Pharmaceuticals, Inc.
 Cylene Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cylene Pharmaceuticals, Inc. discovers, develops and commercializes small molecule drugs. It develops molecule drugs to treat life-threatening diseases, with a particular emphasis in oncology. The firm drug discovery platform, STAND has delivered a diverse portfolio of drug candidates that target the multiple pathways critical for the support, maintenance of cancer cells and that address unmet medical needs with substantial markets. The company was founded in 1997 by Thomas James Farrell and Daniel Douglas Von Hoff and is headquartered in San Diego, CA. | Corporate Officer/Principal | - | - |
Opleiding van Denis Drygin
| University of Massachusetts | Doctorate Degree |
| Moscow State University Lomonosov | Graduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 5 |
| Rusland | 2 |
Operationeel
| Corporate Officer/Principal | 2 |
| Graduate Degree | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
Sectoraal
| Health Technology | 3 |
| Consumer Services | 3 |
| Finance | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| REGULUS THERAPEUTICS INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Pimera, Inc.
Pimera, Inc. Financial ConglomeratesFinance Pimera, Inc. provides investment services. The company is headquartered in San Diego, CA. | Finance |
Cylene Pharmaceuticals, Inc.
Cylene Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cylene Pharmaceuticals, Inc. discovers, develops and commercializes small molecule drugs. It develops molecule drugs to treat life-threatening diseases, with a particular emphasis in oncology. The firm drug discovery platform, STAND has delivered a diverse portfolio of drug candidates that target the multiple pathways critical for the support, maintenance of cancer cells and that address unmet medical needs with substantial markets. The company was founded in 1997 by Thomas James Farrell and Daniel Douglas Von Hoff and is headquartered in San Diego, CA. | Health Technology |
- Beurs
- Insiders
- Denis Drygin
- Ervaring
